CurrentAmbetter NevadaPolicy CP.BH.300

Biofeedback for Behavioral Health Disorders

Defines medical necessity criteria, limits, and clinical guidance for outpatient biofeedback/neurofeedback as an adjunctive treatment for certain behavioral health diagnoses for members/enrollees of Centene Advanced Behavioral Health and affiliated health plans.

Policy Summary

PayerAmbetter Nevada

PolicyBiofeedback for Behavioral Health Disorders

Policy CodePolicy CP.BH.300

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain prior authorization to request up to 25 initial biofeedback sessions and document diagnosis, validated severity scores, treatment plan and practitioner training for review.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

up to 25initial sessions

up to 20continuation sessions

25%required improvement for continuation

50%discharge threshold

anxiety, PTSDcovered indications

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Initial Therapy

Covered when ALL of the following are met

Initial behavioral health biofeedback (up to 25 sessions): A. Diagnosis of anxiety disorder or post-traumatic stress disorder as listed in the most current DSM; B. Significant symptoms interfering with functioning in at least one life area as measured by a widely recognized validated standardized severity scale focused on the symptom profile; C. Member/enrollee is motivated to actively participate in the treatment plan, including practice and follow-through at home; D. Member/enrollee can participate in the treatment plan (physically and intellectually); E. Comprehensive treatment plan includes biofeedback as an adjunctive intervention in addition to other primary evidence-based interventions; F. The condition can be appropriately treated with biofeedback (existing pathology does not prevent success); G. Evidence that standard evidence-based outpatient treatments (including psychotherapy and medication management) are insufficient to treat the condition safely and effectively; H. There is a readily identifiable response measurable by a symptom-specific validated standardized scale; I. Biofeedback training is performed by a physician or qualified non-physician practitioner who has undergone biofeedback training and certification (may include nurse practitioners, physician assistants, qualified mental health professionals, psychologists, and where applicable, biofeedback technicians); J. Individualized treatment plan with clearly stated realistic goals and objectives; K. Treatment is structured to achieve optimum documented benefit; L. There is a documented planned transition out of biofeedback from the start of treatment, which may include ensuring the ability to continue learned techniques independently after sessions end.up to 25 sessions

All elements A through L must be documented

Continuation Therapy

Additional continuation sessions (up to 20) reviewed case-by-case by Medical Director when ALL of the following are met

Continuation (up to an additional 20 sessions): A. Initial criteria continue to be met; B. Session frequency is scheduled at a rate consistent with presenting symptoms and showing results (a lower rate may impede progress); C. Progress related to biofeedback can be clearly described by at least a 25% reduction in severity compared to the last review; D. When medically necessary, appropriate psychopharmacological intervention is provided; E. There is a documented planned transition out of biofeedback from the start of treatment which includes: E.1 a plan ensuring the member can continue biofeedback-learned techniques independently after sessions end; and E.2 a goal with a clear and reasonable score range on a validated scale demonstrating meaningful progress.up to 20 additional sessions

Medical Director review required

Discharge / No longer medically necessary

Discharge or biofeedback deemed no longer medically necessary when ANY one of the following is met

Discontinuation criteria: A. Documented goals and objectives have been substantially achieved; B. Member/enrollee no longer meets initiation or continuation criteria, or symptom severity has dropped by 50%; C. Member/enrollee is not engaging in treatment despite multiple documented attempts to address non-participation; D. Member/enrollee refuses treatment; E. Member/enrollee is not making progress toward treatment goals with no reasonable expectation of progress using this treatment approach; F. It is reasonably predicted that continuing improvement can occur after discontinuation of biofeedback with ongoing psychotherapy, medication management and/or community support.N/A

Any single condition is sufficient for discharge

Unsupported / Experimental

Unsupported uses: Current evidence does not support the safety and efficacy of biofeedback for any behavioral health diagnosis other than those noted in this policy as medically necessary; there is insufficient scientific evidence to support the efficacy of neurosound/biosound treatments typically billed under neurofeedback CPT codes.N/A

These uses are considered unsupported by current evidence

Biofeedback is not supported by current evidence for behavioral health diagnoses outside the limited indications specified in this policy. In particular, therapies described as neurosound/biosound that are sometimes billed under neurofeedback or other biofeedback CPT codes lack sufficient scientific evidence of efficacy and are considered unsupported for behavioral health indications.

Coverage of biofeedback services is subject to the terms, conditions, exclusions, and limitations of the member's coverage documents and applicable plan administrative policies. For Medicaid members, state Medicaid coverage provisions take precedence if they conflict with this clinical policy; providers should consult the applicable state Medicaid manual. The Health Plan may change or withdraw this policy and prior authorization or other administrative requirements may apply per the member's contract.

Current evidence does not support the use of biofeedback for behavioral health diagnoses beyond the anxiety disorders and post-traumatic stress disorder listed as medically necessary in this policy. As noted, there is insufficient scientific evidence to support neurosound/biosound treatments and similar modalities for behavioral health conditions; such uses are considered not medically necessary under this policy.

Provider Actions, Authorization & Documentation Requirements

Prior Authorization

Prior Authorization Required

Prior authorization is required for initial treatment and continuation reviews. Up to 25 initial biofeedback sessions for behavioral health disorders require prior authorization; requests for up to 20 additional continuation sessions will be reviewed case-by-case by a Medical Director. Prior authorization requirements are subject to the member's coverage documents and the Health Plan's administrative policies.

Up to 25 initial sessions require prior authorization
Continuation up to 20 additional sessions reviewed case-by-case

Note

Adjunctive Treatment Requirement

Biofeedback must be provided as an adjunctive intervention — part of a comprehensive treatment plan that includes other primary evidence-based treatments (for example, psychotherapy and/or medication management). The treatment plan must be individualized with realistic goals, structured to achieve documented expected benefit, and include a documented planned transition out of biofeedback from the start of treatment.

Biofeedback is adjunctive to primary evidence-based interventions
Individualized treatment plan with realistic goals and planned transition out of biofeedback

Documentation Required

Required Documentation

Providers must document the clinical rationale and measurable outcomes for biofeedback. Required documentation includes: the DSM diagnosis; evidence of functional impairment on a recognized validated standardized severity scale; an individualized treatment plan with stated goals and objectives; evidence that standard outpatient treatments have been insufficient; the member's motivation and ability to participate; practitioner qualifications/certification; and measurable response using symptom‑specific validated scales.

Document DSM diagnosis and practitioner qualifications
Validated severity scales documenting functional impairment and baseline scores
Individualized treatment plan with goals, expected benefit, and planned transition
Evidence that standard treatments were insufficient and measurable response on validated scales

Denial Risk

Denial Triggers

Requests may be denied if medical necessity criteria or required documentation are not met. Common denial triggers include absence of a covered DSM diagnosis, lack of documented functional impairment on validated scales, no evidence that standard evidence-based treatments were tried or were insufficient, inadequate documentation of individualized goals and planned transition, or lack of qualified provider certification.

No documented DSM diagnosis meeting policy criteria
No validated-scale evidence of functional impairment
No documentation that standard treatments were tried or insufficient
Missing individualized treatment plan, goals, or transition plan
Provider lacks documented biofeedback training/certification

Note

Claims, Coverage & Administrative Notes

Coverage determinations and claims submission must follow the member's coverage documents, state Medicaid provisions where applicable, and Health Plan administrative rules. The Health Plan retains discretion to interpret policy language and apply exclusions, limitations, and administrative requirements.

Follow member's contract and plan-level claim submission rules
State Medicaid provisions override conflicting policy language for Medicaid members
Health Plan may change, amend, or withdraw this clinical policy

Definitions

Definitions — Biofeedback / Neurofeedback

Biofeedback (general)A non-invasive technique enabling an individual to learn to change physiological activity to improve health and performance

Neurofeedback (EEG biofeedback)A type of biofeedback focused on the central nervous system that uses scalp sensors to measure brain electrical activity and provides real-time feedback to help the individual modulate brain function

Adjunctive useBiofeedback/neurofeedback are intended as adjunctive tools to other standard interventions and not as stand-alone treatments

Mechanism (neurofeedback)Sensors detect, amplify, and record brain activity which is processed and fed back to the brain (audio, visual, electrical, magnetic, or tactile stimuli) to induce self-regulation

Evidence summary — Biofeedback / Neurofeedback

Systematic reviews and meta-analyses citedMultiple systematic reviews and meta-analyses of biofeedback/neurofeedback for conditions including OCD, ADHD, anxiety, and depression are referenced (e.g., Ferreira et al. 2019; Enriquez-Geppert et al. 2019; Fernández-Alvarez et al. 2022)

Evidence for anxiety and depressionRecent reviews report mixed but some positive findings for neurofeedback/biofeedback in anxiety and depressive symptoms (e.g., Tolin et al. 2020; Hou et al. 2021; Fernández-Alvarez et al. 2022)

EEG-based neurofeedback reviewsRecent reviews specifically evaluate EEG-based neurofeedback as a therapeutic intervention for depression and other disorders (e.g., Patil et al. 2023; Patil et al. cited)

National guidance referencedCenters for Medicare & Medicaid Services National Coverage Determination for Biofeedback Therapy is cited among the references

90901	Biofeedback training by any modality
90875	30 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with patient), with psychotherapy
90876	45 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy

OpenPayer

Biofeedback for Behavioral Health Disorders

Coverage Criteria for Biofeedback / Neurofeedback

Coding

Provider Actions, Authorization & Documentation Requirements

Treatment Modalities — Neurofeedback and Biofeedback

Visit Limits and Quantity Constraints

Definitions

Background